For those reports saying antibodies were found to cross-react or cross-neutralize with SARS-CoV-2, the causative virus of COVID-19, in populations outside China before December 2019, how relevant are they with the pandemic? Wang Linfa, professor and director from the Emerging Infectious Disease Program at Duke-NUS Medical School, Singapore, explains during a Zoom briefing this week on his latest finding.